Self-Assembled Berberine-Sinapic Acid Nanomedicine for Synergistic Chemotherapy
Molecules · 10.02.2026 · 31 (4) · 621
DOI: 10.3390/molecules31040621 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 10.02.2026. Verfasst von Ying Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China. Hauptthemen laut MEDLINE: Berberine, Coumaric Acids, Nanomedicine, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the China Postdoctoral Science Foundation, the Natural Science Foundation of Henan Province, China Postdoctoral Science Foundation.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Breast cancer ranks among the most prevalent malignant tumors globally, underscoring the urgent need for efficient and low-toxicity treatment strategies. In this study, a novel nanomedicine (BBR-SA) was constructed based on the self-assembled of berberine (BBR) and sinapic acid (SA) for synergistic chemotherapy. Firstly, utilizing π-π stacking, hydrogen bonding, and electrostatic forces between BBR and SA, the BBR-SA achieved a well-defined nanostructure with high drug-loading capacity and favorable water dispersibility. Furthermore, BBR-SA nanomedicine effectively inhibited the proliferation of mouse mammary carcinoma cells (4T1), showing a significantly stronger inhibitory effect than either BBR or SA alone. Moreover, the remarkable anti-tumor effect was obtained after treatment with BBR-SA nanomedicine in vivo, further demonstrating a synergistic therapeutic effect. More importantly, no significant systemic toxicity was observed after 28 days of intravenous administration with BBR-SA nanomedicine. In summary, the BBR-SA nanomedicine represents a safe and effective therapeutic strategy for breast cancer, offering new perspectives on the application of the traditional chinese medicine in anti-tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
ORCID-Profile: Weisheng Feng
Förderung
- the China Postdoctoral Science Foundation
- the Natural Science Foundation of Henan Province
- China Postdoctoral Science Foundation
- Natural Science Foundation of Henan Province
Zitieren
APA
Zhao, Y., Lu, Y., Ma, Y., Wang, S., Lv, P., Xu, H., Li, Y., & Feng, W. (2026). Self-Assembled Berberine-Sinapic Acid Nanomedicine for Synergistic Chemotherapy. Molecules, 31(4), 621. https://doi.org/10.3390/molecules31040621
Vancouver
Zhao Y, Lu Y, Ma Y, Wang S, Lv P, Xu H, et al. Self-Assembled Berberine-Sinapic Acid Nanomedicine for Synergistic Chemotherapy. Molecules. 2026;31(4):621. doi:10.3390/molecules31040621
BibTeX
@article{Zhao2026,
author = {Zhao, Ying and Lu, Yubo and Ma, Yushan and Wang, Sijia and Lv, Pin and Xu, Huifang and Li, Yuanyuan and Feng, Weisheng},
title = {Self-Assembled Berberine-Sinapic Acid Nanomedicine for Synergistic Chemotherapy},
journal = {Molecules},
year = {2026},
volume = {31},
number = {4},
pages = {621},
doi = {10.3390/molecules31040621}
}
EUVIMED